Skip to content

Weekday Japan business intelligence for finance professionals.

Join the list
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.

Article Archive

All Tokyo Brief articles

2782 articles · newest first

  1. Sep 14, 2026 · 3 min read

    Healthcare REIT Buys 14 Properties for ¥21.7bn, Funds Deal With Equity and Bank Debt

    Healthcare & Medical Investment Corporation tapped an ¥8.8bn share sale and lined up ¥11.1bn in bank loans to acquire 14 senior-care properties and a Tokyo hospital site, a deal that pushes its portfolio toward the largest healthcare-property base among Japan's listed REITs and reshapes near-term payout guidance.

  2. Sep 14, 2026 · 3 min read

    Enigmo Races a Tokyo Stock Exchange Deadline as Consolidated Losses Widen

    Enigmo's free-float market value, at ¥9.04bn, remains below the ¥10bn Tokyo Stock Exchange Prime threshold, and the BUYMA operator has until the end of January to close the gap even as consolidated first-half losses widened and the core marketplace's transaction volume kept sliding.

  3. Sep 14, 2026 · 2 min read

    REVOLUTION Misses Earnings Deadline Again as Its Auditor Still Won't Sign Off

    The Tokyo Standard-listed real estate group could not get its third-quarter earnings reviewed in time because its auditor, Aria Audit Corporation, has withheld a conclusion since June, and an internal probe found 28 of 251 affiliated property funds were wrongly booked as real estate deals rather than financial ones, pushing REVOLUTION toward correcting two years of past filings.

  4. Sep 14, 2026 · 2 min read

    MATSUMOTO INC. Flags Going-Concern Doubt as Quarterly Cash Halves

    MATSUMOTO INC., the Tokyo-listed school-album and commercial printer, says a fourth straight year of negative operating cash flow has left its funding for the next twelve months uncertain, after quarterly cash fell to ¥313.9mn from ¥676.7mn even as its net loss narrowed to ¥100mn.

  5. Sep 14, 2026 · 2 min read

    FDA grants priority review to Takeda's psoriasis pill zasocitinib, decision due by March 2027

    The FDA has accepted Takeda's application for zasocitinib, a once-daily pill for moderate-to-severe plaque psoriasis, for priority review, with a decision due in the first quarter of 2027; across two phase 3 trials roughly 70% of patients reached clear or almost-clear skin by 16 weeks, well ahead of both placebo and the comparator drug apremilast, though Takeda says the filing itself does not change its earnings outlook for the year to March 2027.

  6. Sep 14, 2026 · 2 min read

    BIS and IOSCO Open Comment Window on FMI Cyber Resilience and Vendor Risk

    Market participants have until December 1 to comment, in English, on two consultation papers from BIS's payments committee and IOSCO covering cyber resilience and third-party vendor dependency at financial market infrastructure, after Japan's FSA posted a notice pointing to the original documents.

  7. Sep 14, 2026 · 2 min read

    FSA Drafts New Tagging Rules for Japan's Mandatory Sustainability Disclosures

    Japan's Financial Services Agency has proposed a standalone XBRL taxonomy, built on the IFRS Foundation's own sustainability tags, for the disclosures companies must start filing under the country's new Sustainability Disclosure Standards, with public comments due October 13 and the tags required from reports covering the year to March 2027.

  8. Sep 11, 2026 · 2 min read

    Shikoku Electric's Grid Arm Locks In ¥33.8bn Wheeling-Rate Increase

    Shikoku Electric Power Transmission & Distribution will lift wheeling charges across every voltage class from November 1, adding a net ¥33.8bn to projected revenue over two years, but the parent utility still has not decided how much of that increase reaches retail electricity bills.

  9. Sep 11, 2026 · 2 min read

    Kansai's Grid-Access Charges Rise Across Every Voltage Class From November

    Kansai Transmission and Distribution's METI filing raises wheeling tariffs at every voltage level from November 1, with low-voltage connections taking the biggest hit, up ¥1.22 to ¥9.04 per kWh, a cost retail electricity suppliers pay before any pass-through to customer bills is decided.

Articles | Tokyo Brief